• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ell3 作为干细胞衰老和凋亡的交汇点的关键决策者发挥作用。

Ell3 functions as a critical decision maker at the crossroad between stem cell senescence and apoptosis.

机构信息

Department of Biomedical Science, College of Life Science and CHA Stem Cell Institute, CHA University, 335, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 463-400, Korea.

出版信息

Stem Cell Res Ther. 2019 Jan 17;10(1):32. doi: 10.1186/s13287-019-1137-9.

DOI:10.1186/s13287-019-1137-9
PMID:30654843
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6335702/
Abstract

BACKGROUND

Ell3 is a RNA polymerase II elongation factor that has various cell type-dependent functions, such as regulating the differentiation efficiency of embryonic stem cells and sensitizing cancer cells to anticancer drugs. However, there has been little research on the role of Ell3 on the regulation of senescence and apoptosis of stem cells.

METHODS

We analyzed the senescence of Ell3-suppressed stem cells by mitochondrial activity, β-gal (+) cells, and lineage differentiation efficiency. The apoptosis of Ell3-overexpressing stem cells was analyzed by Annexin V staining, Immunoblot, and Live&dead assay. In addition, chromatin immunoprecipitation and luciferase assays were used to demonstrate p53 functions as a direct transcriptional activator of Ell3.

RESULTS

Suppression of Ell3 expression induced senescence in stem cells by increasing Bcl-2 expression. Unlike the effect of Ell3 suppression, the ectopic expression of Ell3 induces apoptosis of stem cells and induces apoptosis of adjacent cells. In addition, p53 functions as a direct transcriptional activator of Ell3 during the stem cell apoptosis.

CONCLUSIONS

We suggest that the function of Ell3 is associated with the p53-Bcl2 axis in both senescent and apoptotic ADSCs.

摘要

背景

Ell3 是 RNA 聚合酶 II 延伸因子,具有多种细胞类型依赖性功能,例如调节胚胎干细胞的分化效率和使癌细胞对抗癌药物敏感。然而,关于 Ell3 对干细胞衰老和凋亡的调节作用的研究甚少。

方法

我们通过线粒体活性、β-gal(+)细胞和谱系分化效率分析 Ell3 抑制的干细胞衰老。通过 Annexin V 染色、免疫印迹和 Live&Dead 测定分析 Ell3 过表达干细胞的凋亡。此外,还使用染色质免疫沉淀和荧光素酶测定来证明 p53 作为 Ell3 的直接转录激活因子的功能。

结果

抑制 Ell3 表达通过增加 Bcl-2 表达诱导干细胞衰老。与 Ell3 抑制的作用不同,Ell3 的异位表达诱导干细胞凋亡,并诱导相邻细胞凋亡。此外,p53 在干细胞凋亡过程中作为 Ell3 的直接转录激活因子发挥作用。

结论

我们表明 Ell3 的功能与 p53-Bcl2 轴在衰老和凋亡 ADSC 中都有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20de/6335702/75027a503654/13287_2019_1137_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20de/6335702/6f3ceb4d3410/13287_2019_1137_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20de/6335702/b8e8611dd075/13287_2019_1137_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20de/6335702/bb0d7aae01df/13287_2019_1137_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20de/6335702/94e09326c668/13287_2019_1137_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20de/6335702/75027a503654/13287_2019_1137_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20de/6335702/6f3ceb4d3410/13287_2019_1137_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20de/6335702/b8e8611dd075/13287_2019_1137_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20de/6335702/bb0d7aae01df/13287_2019_1137_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20de/6335702/94e09326c668/13287_2019_1137_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20de/6335702/75027a503654/13287_2019_1137_Fig5_HTML.jpg

相似文献

1
Ell3 functions as a critical decision maker at the crossroad between stem cell senescence and apoptosis.Ell3 作为干细胞衰老和凋亡的交汇点的关键决策者发挥作用。
Stem Cell Res Ther. 2019 Jan 17;10(1):32. doi: 10.1186/s13287-019-1137-9.
2
Ell3 enhances differentiation of mouse embryonic stem cells by regulating epithelial-mesenchymal transition and apoptosis.Ell3 通过调控上皮间质转化和细胞凋亡促进小鼠胚胎干细胞的分化。
PLoS One. 2012;7(6):e40293. doi: 10.1371/journal.pone.0040293. Epub 2012 Jun 29.
3
Ell3 stimulates proliferation, drug resistance, and cancer stem cell properties of breast cancer cells via a MEK/ERK-dependent signaling pathway.Ell3 通过 MEK/ERK 依赖性信号通路刺激乳腺癌细胞的增殖、耐药性和癌症干细胞特性。
Biochem Biophys Res Commun. 2013 Aug 9;437(4):557-64. doi: 10.1016/j.bbrc.2013.06.114. Epub 2013 Jul 9.
4
Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells.在乳腺癌细胞中,Ell3通过其对泛素依赖性和非依赖性蛋白酶体降解途径的作用,在顺铂治疗后稳定p53。
Oncotarget. 2015 Dec 29;6(42):44523-37. doi: 10.18632/oncotarget.5972.
5
The RNA Pol II elongation factor Ell3 marks enhancers in ES cells and primes future gene activation.RNA 聚合酶 II 延伸因子 Ell3 在胚胎干细胞中标记增强子,并启动未来的基因激活。
Cell. 2013 Jan 17;152(1-2):144-56. doi: 10.1016/j.cell.2012.12.015. Epub 2012 Dec 27.
6
Ell3 stimulates 5-FU resistance in a breast cancer cell line.Ell3在一种乳腺癌细胞系中促进5-氟尿嘧啶耐药。
Oncol Lett. 2017 Jun;13(6):4173-4179. doi: 10.3892/ol.2017.5996. Epub 2017 Apr 5.
7
Depletion of securin induces senescence after irradiation and enhances radiosensitivity in human cancer cells regardless of functional p53 expression.抑失活 securin 会在照射后诱导衰老,并增强人类癌细胞的放射敏感性,而与功能性 p53 表达无关。
Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):566-74. doi: 10.1016/j.ijrobp.2009.12.013.
8
Characterization of the molecular mechanisms for p53-mediated differentiation.p53介导分化的分子机制表征
Cell Growth Differ. 2000 Nov;11(11):561-71.
9
Griffipavixanthone induces apoptosis of human breast cancer MCF-7 cells in vitro.格里菲帕黄酮诱导人乳腺癌 MCF-7 细胞体外凋亡。
Breast Cancer. 2019 Mar;26(2):190-197. doi: 10.1007/s12282-018-0912-2. Epub 2018 Sep 26.
10
Induction of apoptosis and cellular senescence in mice lacking transcription elongation factor, Elongin A.缺乏转录延伸因子延伸蛋白A的小鼠中细胞凋亡和细胞衰老的诱导
Cell Death Differ. 2007 Apr;14(4):716-26. doi: 10.1038/sj.cdd.4402067. Epub 2006 Dec 15.

本文引用的文献

1
Senescence promotes in vivo reprogramming through p16 and IL-6.衰老通过 p16 和 IL-6 促进体内重编程。
Aging Cell. 2018 Apr;17(2). doi: 10.1111/acel.12711. Epub 2017 Dec 27.
2
Mechanisms of transcriptional regulation by p53.p53 的转录调控机制。
Cell Death Differ. 2018 Jan;25(1):133-143. doi: 10.1038/cdd.2017.174. Epub 2017 Nov 10.
3
Ell3 Modulates the Wound Healing Activity of Conditioned Medium of Adipose-derived Stem Cells.Ell3调节脂肪来源干细胞条件培养基的伤口愈合活性。
Dev Reprod. 2017 Sep;21(3):335-342. doi: 10.12717/DR.2017.21.3.335. Epub 2017 Sep 30.
4
HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2.HSP90 抑制剂(NVP-AUY922)增强了表达 BCL-2 的小细胞肺癌中 BCL-2 抑制剂(ABT-737)的抗癌作用。
Cancer Lett. 2017 Dec 28;411:19-26. doi: 10.1016/j.canlet.2017.09.040. Epub 2017 Oct 4.
5
FOXP1 controls mesenchymal stem cell commitment and senescence during skeletal aging.FOXP1在骨骼衰老过程中控制间充质干细胞的定向分化和衰老。
J Clin Invest. 2017 Apr 3;127(4):1241-1253. doi: 10.1172/JCI89511. Epub 2017 Feb 27.
6
Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?间充质干细胞的命运抉择:脂肪细胞还是成骨细胞?
Cell Death Differ. 2016 Jul;23(7):1128-39. doi: 10.1038/cdd.2015.168. Epub 2016 Feb 12.
7
Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells.在乳腺癌细胞中,Ell3通过其对泛素依赖性和非依赖性蛋白酶体降解途径的作用,在顺铂治疗后稳定p53。
Oncotarget. 2015 Dec 29;6(42):44523-37. doi: 10.18632/oncotarget.5972.
8
Clinical Trials With Mesenchymal Stem Cells: An Update.间充质干细胞的临床试验:最新进展
Cell Transplant. 2016;25(5):829-48. doi: 10.3727/096368915X689622. Epub 2015 Sep 29.
9
Characterization of bone marrow-derived mesenchymal stem cells in aging.衰老过程中骨髓间充质干细胞的特征分析
Bone. 2015 Jan;70:37-47. doi: 10.1016/j.bone.2014.10.014. Epub 2014 Oct 28.
10
Initiation of premature senescence by Bcl-2 in hypoxic condition.在缺氧条件下,Bcl-2引发细胞早衰。
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2446-53. eCollection 2014.